Literature DB >> 7021101

Percentage of cells in the S phase of the cell cycle in human lymphoma determined by flow cytometry.

R C Braylan, L W Diamond, M L Powell, B Harty-Golder.   

Abstract

The percentage of cells with S phase DNA content (S cells) was determined by flow cytometry in cell suspensions obtained from 27 patients with non-Hodgkin's lymphomas. DNA was measured in ethanol-fixed cells stained with propidium iodide after RNase treatment. Cells from 17 samples were also exposed to [3H]-thymidine and labeling indices were determined. An excellent linear correlation was observed between the percentage of S cells calculated by flow cytometry and the labeling index (r = 0.95). To determine the relationship between the percentage of S cells and the clinical behavior of the tumors, the survival of the 27 patients was analyzed. None of the patients was undergoing antineoplastic therapy at the time of the study. The patients were separated into 2 groups according to the percentage of S cells calculated by flow cytometry: those with less than 5% S cells and those with higher than 5% S cells. Clinical follow-up ranged from 5 to 20 months. While 7 of 12 patients with tumors containing more than 5% S cells have died of lymphoma (median survival, 9 months), there has been only one death from lymphoma among 15 patients with tumors containing less than 5% S cells. The difference in survival between these two groups is statistically significant (P = 0.01).

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7021101     DOI: 10.1002/cyto.990010302

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  26 in total

Review 1.  Proliferation indices in malignant lymphomas.

Authors:  J Crocker
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

2.  Pathology-important advances in clinical medicine: the flow cytometer in the clinical laboratory.

Authors:  H Simpkins
Journal:  West J Med       Date:  1984-07

3.  Pathology-important advances in clinical medicine: the role of coronary collateral arteries in myocardial ischemia.

Authors:  R J Lammers; C M Bloor
Journal:  West J Med       Date:  1984-07

4.  Pathology-important advances in clinical medicine: current trends in drug overdose.

Authors:  M M McCarron
Journal:  West J Med       Date:  1984-07

5.  In vitro modulation of the metastatic phenotype. I. Analysis of differentiation forms of the B16 melanoma expressing Met-72 determinants and metastatic activity.

Authors:  J H Xiang; A K Kimura
Journal:  Clin Exp Metastasis       Date:  1986 Oct-Dec       Impact factor: 5.150

6.  Murine melanoma cells incomplete reprogramming using non-viral vector.

Authors:  D A D Câmara; A S Porcacchia; A S Costa; R A Azevedo; I Kerkis
Journal:  Cell Prolif       Date:  2017-06-15       Impact factor: 6.831

Review 7.  Review: assessment of cell proliferation in histological material.

Authors:  P A Hall; D A Levison
Journal:  J Clin Pathol       Date:  1990-03       Impact factor: 3.411

8.  Expression of the eukaryotic translation initiation factors 4E and 2alpha in non-Hodgkin's lymphomas.

Authors:  S Wang; I B Rosenwald; M J Hutzler; G A Pihan; L Savas; J J Chen; B A Woda
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

9.  Cell proliferation in non-Hodgkin's lymphomas. Digital image analysis of Ki-67 antibody staining.

Authors:  B R Schwartz; G Pinkus; S Bacus; M Toder; D S Weinberg
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

10.  Proliferation in non-Hodgkin's lymphoma: a comparison of Ki-67 staining on fine needle aspiration and cryostat sections.

Authors:  D C Brown; K C Gatter; D Y Mason
Journal:  J Clin Pathol       Date:  1990-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.